Azodopa is the first photoswitchable dopamine agonist with demonstrated efficacy in wild-type animals

we present the analysis of a series of GPCRs whose activity has been shown to affect the lifespan of animal

structure-based technology has passed a key test, in enabling the discovery of orally available small molecules aimed

Nyla Naim, Dr. Michael Lemieux & Dr. Jason Nasse About Dr. Nyla Naim Nyla is a Senior Scientist on the Scientific Support Team at Addgene . Nyla supports biomedical research by connecting researchers with resources and promoting reproducible Nyla Naim on the web LinkedIn Dr. GPCR Ecosystem About Dr.

Sponsors GPCR Retreat Program < Back to schedule Biased agonism at the GLP-1 receptor: from structure to animal

Nicolas Gilles is an expert in the study of animal toxins. He is pioneering the investigation of animal toxins acting on GPCRs, the largest therapeutic target class